Selective endothelin A receptor antagonism with sitaxentan reduces neointimal lesion size in a mouse model of intraluminal injury

Publisher： John Wiley & Sons Inc

E-ISSN： 1476-5381|172|11|2827-2837

ISSN： 0007-1188

Source： BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol.172, Iss.11, 2015-06, pp. : 2827-2837

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Endothelin receptor antagonism in pulmonary arterial hypertension – a role for selective ETA inhibition?

By Jacobs Avrum   Preston Ioana R.   Gomberg-Maitland Mardi  

Current Medical Research and Opinion, Vol. 22, Iss. 12, 2006-12 ,pp. : 2567-2574

Informa Healthcare

Access to resources Recommend Favorite

Interferon-γ deficiency reduces neointimal formation in a model of endoluminal endothelial injury combined with atherogenic diet

By          

International Journal of Molecular Medicine, Vol. 30, Iss. 3, 2012-01 ,pp. : 545-552

Spandidos Publications

Access to resources Recommend Favorite

Dual farnesoid X receptor/TGR5 agonist INT‐767 reduces liver injury in the Mdr2−/− (Abcb4−/−) mouse cholangiopathy model by promoting biliary HCO 3− output

By  

HEPATOLOGY, Vol. 54, Iss. 4, 2011-10 ,pp. : 1303-1312

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Mouse Model of Aortic Angioplasty for Genomic Studies of Neointimal Hyperplasia

By  

Journal of Vascular Research, Vol. 42, Iss. 4, 2005-07 ,pp. : 292-300

Karger

Access to resources Recommend Favorite

Enterocolitis causes profound lymphoid depletion in endothelin receptor B‐ and endothelin 3‐null mouse models of Hirschsprung‐associated enterocolitis

By  

EUROPEAN JOURNAL OF IMMUNOLOGY, Vol. 45, Iss. 3, 2015-03 ,pp. : 807-817

John Wiley & Sons Inc

Access to resources Recommend Favorite